William W Tseng, MD is Assistant Professor of Surgery at the Keck School of Medicine at USC. He obtained his undergraduate and medical degrees from Northwestern University, under the Honors Program in Medical Education. He did residency training in General Surgery at the University of California at San Francisco and then completed subspecialty fellowship training in Surgical Oncology at the University of Texas M.D. Anderson Cancer Center.
Dr. Tseng‘s clinical focus and expertise is in soft tissue sarcoma and melanoma. He has published extensively and won several awards for work done in both of these disease areas. Dr. Tseng’s research interest is in tumor immunology and immunotherapy. He completed dedicated research fellowships in immunology at Stanford University and M.D. Anderson.
The Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG): "Red wine or white"? Ann Surg Oncol. The Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG): "Red wine or white"? Ann Surg Oncol. 2016 Dec; 23(13):4418-4420. View in: PubMed
The role of margins in extremity soft tissue sarcoma. J Surg Oncol. 2016 Mar; 113(3):333-8. View in: PubMed
Hypothesis: The Intratumoral Immune Response against a Cancer Progenitor Cell Impacts the Development of Well-Differentiated versus Dedifferentiated Disease in Liposarcoma. Front Oncol. 2016; 6:134. View in: PubMed
Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma. Cancer. 2015 Oct 15; 121(20):3659-67. View in: PubMed
Contemporary Management of Retroperitoneal Soft Tissue Sarcomas. Curr Oncol Rep. 2015 Aug; 17(8):462. View in: PubMed
Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management. BMJ Case Rep. 2015 Jul 08; 2015. View in: PubMed
Follow-up of the soft tissue sarcoma patient. J Surg Oncol. 2015 Apr; 111(5):641-5. View in: PubMed
Analysis of the intratumoral adaptive immune response in well differentiated and dedifferentiated retroperitoneal liposarcoma. Sarcoma. 2015; 2015:547460. View in: PubMed
Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? Ann Surg Oncol. Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? Ann Surg Oncol. 2014 Jul; 21(7):2136-43. View in: PubMed
Potential for immunotherapy in soft tissue sarcoma. Hum Vaccin Immunother. 2014; 10(11):3117-24. View in: PubMed
Novel systemic therapies in advanced liposarcoma: a review of recent clinical trial results. Cancers (Basel). 2013 May 10; 5(2):529-49. View in: PubMed
Lymphocyte composition and distribution in inflammatory, well-differentiated retroperitoneal liposarcoma: clues to a potential adaptive immune response and therapeutic implications. Am J Surg Pathol. 2012 Jun; 36(6):941-4. View in: PubMed
Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures. World J Surg Oncol. 2011 Nov 04; 9:143. View in: PubMed